EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Acute Respiratory Distress Syndrome Due to COVID-19-Associated Pulmonary Aspergillosis with Rare Extensive Tracheobronchial Pseudomembranous Involvement: A Case Report

Liu He, Wei Wang, Danyan Cai, Xiaoshan Zhang, Xinyuan Tan

Mycopathologia · 2025

DOI: 10.1007/s11046-025-00971-5 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Mycopathologia, 2025. Verfasst von Liu He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Public Health, City University of Hong Kong, Hong Kong, 999077, China. Hauptthemen laut MEDLINE: COVID-19, Respiratory Distress Syndrome, Invasive Pulmonary Aspergillosis, Pulmonary Aspergillosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19-associated pulmonary aspergillosis (CAPA) significantly exacerbates the clinical outcomes of COVID-19 patients, contributing to heightened mortality. Aspergillus tracheobronchitis, a manifestation of invasive pulmonary aspergillosis, specifically involves the tracheobronchial tree. According to the 2020 European Confederation of Medical Mycology/International Society for Human and Animal Mycology (ECMM/ISHAM) consensus criteria, airway biopsy via bronchoscopy is the definitive method for CAPA diagnosis, underscoring its critical role in the management of COVID-19 patients. This case report describes an elderly male patient with COVID-19 who presented with extensive pseudomembranous involvement of the tracheobronchial tree, identified through bronchoscopy. The pseudomembrane, spanning from the glottis to the bronchi and characterized by its yellow-white translucency, was removed. Subsequent pathological examination and next-generation sequencing confirmed an Aspergillus infection. Despite the initiation of antifungal therapy, the patient's condition deteriorated, leading to his death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Distress SyndromeInvasive Pulmonary AspergillosisPulmonary AspergillosisHumansMaleFatal OutcomeSARS-CoV-2BronchoscopyAntifungal AgentsAged

Stichwörter der Autor:innen

Aspergillus tracheobronchitisAcute respiratory distress syndromeCOVID-19-associated pulmonary aspergillosisCase reportExtensive tracheobronchial pseudomembraneFungal infectionPseudomembranous Aspergillus tracheobronchitis

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases and Public Health, City University of Hong Kong, Hong Kong, 999077, China.
  • PCCM, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
  • Department of Global Public Health, Health Systems and Policy, Karolinska Institutet, 17177, Stockholm, Sweden.
  • PCCM, Chongqing Traditional Chinese Medicine Hospital, Chongqing, 400021, China.
  • PCCM, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China. tantcm007@163.com.

Zitieren

APA

He, L., Wang, W., Cai, D., Zhang, X., & Tan, X. (2025). Acute Respiratory Distress Syndrome Due to COVID-19-Associated Pulmonary Aspergillosis with Rare Extensive Tracheobronchial Pseudomembranous Involvement: A Case Report. Mycopathologia. https://doi.org/10.1007/s11046-025-00971-5

Vancouver

He L, Wang W, Cai D, Zhang X, Tan X. Acute Respiratory Distress Syndrome Due to COVID-19-Associated Pulmonary Aspergillosis with Rare Extensive Tracheobronchial Pseudomembranous Involvement: A Case Report. Mycopathologia. 2025. doi:10.1007/s11046-025-00971-5

BibTeX
@article{He2025,
  author = {He, Liu and Wang, Wei and Cai, Danyan and Zhang, Xiaoshan and Tan, Xinyuan},
  title = {Acute Respiratory Distress Syndrome Due to COVID-19-Associated Pulmonary Aspergillosis with Rare Extensive Tracheobronchial Pseudomembranous Involvement: A Case Report},
  journal = {Mycopathologia},
  year = {2025},
  doi = {10.1007/s11046-025-00971-5}
}
Kostenlos starten →